Median (Q1, Q3) LDL-C at baseline was 398 (343, 475) mg/dL, and all patients were on statins (atorvastatin or rosuvastatin) and ezetimibe
If its painful, spreading, interfering with sleep, or getting worse after a dose increase, its worth asking whether staying at your current dose, lowering the dose, or pausing treatment makes sense
These side effects typically diminish as the body adjusts, but understanding what to expect helps patients prepare rather than panic
Based on comparative clinical trial data, Retatrutide has demonstrated the potential for both a faster rate of weight loss and a higher overall percentage of total body weight loss at similar time points
The company has disclosed three new biosimilar oncology assets, trastuzumab subcutaneous, nivolumab and pembrolizumab, targeting reference products Herceptin SC, Opdivo and Keytruda respectively, therapies that together generated over $40 billion in global sales in 2024
Semaglutide works by mimicking the GLP-1 hormone, which helps regulate blood sugar and control appetite
